Description
As seasons change and environmental factors impact our health, the risk of respiratory infections increases, particularly for the elderly and those with chronic conditions. RSV can lead to serious complications like pneumonia, bronchitis, and otitis media, affecting those with weakened immunity. Our RSV vaccine offers excellent prevention with just one dose for long-term protection. Schedule your vaccination today and let our professional medical team provide comprehensive vaccination services to protect your respiratory health!
Respiratory Syncytial Virus (RSV) Vaccine
Respiratory Syncytial Virus (RSV) Vaccine: The Only Vaccine Suitable for Ages 50+ with Patented Recombinant Adjuvant A501E
The RSV vaccine is designed to prevent infections caused by the Respiratory Syncytial Virus (RSV), a virus that leads to respiratory illnesses, often causing infections in the airways, lungs, and middle ear. It is particularly suitable for individuals aged 50 and above, as well as those with chronic conditions. This vaccine effectively reduces the risk of RSV infection and minimizes the likelihood of complications following infection. A single dose provides 94.6% protection. Schedule your RSV vaccination today to safeguard your respiratory health.
Don’t Ignore the Deadly Threat of RSV: Mortality Rate as High as 17.6%!
Respiratory Syncytial Virus (RSV) is a highly contagious respiratory virus primarily spread through droplets, direct contact, or contaminated surfaces. While most healthy individuals experience mild, cold-like symptoms (such as runny nose, cough, or fever) upon infection, RSV can be deadly for vulnerable groups—particularly the elderly, individuals with chronic illnesses, and infants. Studies show that the mortality rate among older adults infected with RSV can reach as high as 17.6%.
The Deadly Cascade Effect of RSV in Patients with Chronic Conditions
For individuals with chronic diseases, RSV infection can exacerbate existing conditions, creating a vicious cycle:
| Condition | Risk Multiplier | Pathological Impact |
|---|---|---|
| Chronic Obstructive Pulmonary Disease (COPD) | 13.4x | Impaired lung function → Worsened oxygen deprivation → Increased risk of respiratory failure |
| Cardiovascular Disease | 6.5x | Virus triggers systemic inflammation → Increased cardiac strain → Heart failure or myocardial infarction |
| Diabetes | 6.4x | High blood sugar weakens immunity → Accelerated viral replication → Higher risk of sepsis or ketoacidosis |
| Chronic Kidney Disease | 9.7x | Reduced kidney function → Accumulation of metabolic waste → Multi-organ failure |
Recommended:
Recommendations for individuals aged 60 and above, especially those with chronic illnesses, to receive early vaccination:
- Only one dose is required, effectively reducing the risk of RSV infection and the likelihood of developing complications after infection.
- 82.6% efficacy*: Protects against lower respiratory tract diseases caused by respiratory syncytial virus (RSV).
- 94.6% efficacy*: Protects individuals with at least one coexisting condition.
Clinical features
RSV causes respiratory tract diseases such as infection of the airway, lungs and middle ear. It is the most common cause of bronchiolitis and pneumonia for those under 1 year of age. Patients develop fever and other symptoms such as runny nose, cough, headache, decreased appetite, body ache or weakness, and occasionally otitis media.
Complications of Severe Infections
Severe infections can spread to the lower respiratory tract, leading to pneumonia, middle ear infections, or inflammation of the small airways. Typically, common symptoms resolve within one to two weeks of recovery. However, in cases of severe illness, patients may continue to experience symptoms such as asthma even after two weeks.
Mode of transmission
The virus can be transmitted by direct contact with infectious secretions, by droplets spread, or indirectly through contaminated hands, eating utensils or articles freshly soiled by nasal or throat discharges of an infected person.
Incubation period
The incubation period is 1 – 10 days, usually 5 – 7 days.
Management
The infection usually subsides in about 1 – 2 weeks
Instructions for use：
- Must be used on or before the expiration date
- Please show your confirmation information, order number, registered full name and phone number for verification
Terms and Conditions:
- This voucher is only valid for Trinity Medical Centre.
- The vaccine must be given within 90 days after purchase of this voucher. This voucher can be used at Central, Causeway Bay or Tsim Sha Tsui Trinity Medical Centre. The validity period will not be extended by this voucher.
- This voucher is non-refundable and cannot be redeemed for full or partial cash.
- You must bring this ticket to the front desk when you register.
- This voucher cannot be used with any other special offers and promotions.
- If this voucher is lost or stolen, we will not accept any liability and will not provide any reissue in such case.
- If you have any questions, please call 2192 7022 or email tmc@trinitymedical.com.hk
- Trinity Medical Centre reserves the right to amend the above Terms and Conditions without prior notice. In case of any disputes, Trinity Medical Centre reserves all rights for final decision
*Vaccination may not protect all recipients;
*Comorbidities of interest: chronic obstructive pulmonary disease (COPD), asthma, any chronic respiratory / pulmonary disease, chronic heart failure, diabetes mellitus type 1 or type 2, and advanced liver or renal disease (endocrine metabolic)
